Search results - 286 results
Healthcare-Associated Infections and Antimicrobial Use in Belgian Acute Care Hospitals: Results of the 2022 ECDC Point Prevalence Survey
HAI s and antimicrobial use in Belgian acute care hospitals compared to previous surveys. This emphasizes the ongoing need for rigorous infection prevention and control measures, as well as robust ...
Antimicrobial Use in Belgian Acute Care Hospitals: Results of the 2022 ECDC Point Prevalence Survey
All patients present in surveyed wards at 8 a.m. on the PPS day and not discharged at that time were included. Infection prevention and control teams collected comprehensive data on hospitals, wards, ...
Herpes zoster in Belgium: a new solution to an old problem
~ 30%. Management of HZ can be challenging due to limited efficacy of oral antivirals on pain control, and neuropathic pain that may require aggressive management. Post-herpetic neuralgia (PHN) can cause ...
Prevalence of Healthcare-Associated Infections in Belgian Acute Care Hospitals in 2022: Results of ECDC Point Prevalence Survey
HAI s and associated factors. The increased prevalence of HAI s revealed in 2022 highlights the need for continuous improvement in infection prevention and control measures. Health Topics: ...
Quality indicators for infection prevention and control in Belgian acute hospitals- Supplement report 2023
Number: D/2024.14.440/24 URL: https://www.sciensano.be/en/projects/quality-indicators-infection-prevention-and-control-acute-hospitals Keywords: infection prevention and control IPC programme quality of ...
Quality indicators for infection prevention and control in acute care hospitals- Report 2023- Data up to and including 2022
Number: D/2024.14.440/24 Keywords: Antimicrobial resistance Belgian Acute Hospitals healthcare associated infections infection prevention and control IPC IPC programme quality indicators quality of care ...
Regulatory workshop on challenge strain development and GMP manufacture- A stakeholder meeting report.
challenge agent strains for Controlled Human Infection Model (CHIM) studies. Developers are often uncertain about which GMP requirements or regulatory guidelines apply but should be guided by the 2022 ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
effectiveness (VE) in participating European countries since early 2021.AimWe aimed to measure VE against PCR-confirmed SARS-CoV-2 in patients ≥ 20 years hospitalised with severe acute respiratory infection ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
2021.MethodsForty-six participating hospitals across 14 countries follow a similar generic protocol using the test-negative case-control design. We defined complete primary series vaccination (PSV) as two doses of ...
A genomic appraisal of invasive Salmonella Typhimurium and associated antibiotic resistance in sub-Saharan Africa.
Drug Resistance, Microbial Genomics Humans Salmonella Infections Salmonella typhimurium Abstract: Invasive non-typhoidal Salmonella (iNTS) disease manifesting as bloodstream infection with high mortality ...